Ye Cao

926 total citations
32 papers, 477 citations indexed

About

Ye Cao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ye Cao has authored 32 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Ye Cao's work include Aquaculture disease management and microbiota (5 papers), Antimicrobial Peptides and Activities (3 papers) and Animal Virus Infections Studies (3 papers). Ye Cao is often cited by papers focused on Aquaculture disease management and microbiota (5 papers), Antimicrobial Peptides and Activities (3 papers) and Animal Virus Infections Studies (3 papers). Ye Cao collaborates with scholars based in China, United States and Hong Kong. Ye Cao's co-authors include Ying Jin, Xiu-Yu Cai, Yuchen Cai, Wenqi Jiang, Wei‐Han Hu, Weidong Zhang, Yanxia Shi, Wen-Qi Jiang, Yan-Xia Shi and Lingfeng Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Ye Cao

31 papers receiving 470 citations

Peers

Countries citing papers authored by Ye Cao

Since Specialization

Citations

This map shows the geographic impact of Ye Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Cao more than expected).

Fields of papers citing papers by Ye Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Cao. The network helps show where Ye Cao may publish in the future.

Co-authorship network of co-authors of Ye Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Cao. A scholar is included among the top collaborators of Ye Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Cao. Ye Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Boron Neutron Capture Therapy as a Novel Approach for Chondrosarcoma: Case Study of Tumor Reduction and Long-term Control 2025 ·Advances in Radiation Oncology ·Jinsheng Hong, Yuan‐Hao Liu, Xiaohua Zhu, (unknown), Xiaodong Lin, Diyun Shu, Youqun Lai, Ye Cao, (unknown), (unknown), (unknown), (unknown), Xingyan Liu, Ping Zhou, (unknown), Mingang Ying, (unknown), (unknown)	2
2	Efficacy of PARPi re-maintenance therapy for recurrent ovarian cancer 2025 ·Frontiers in Oncology ·(unknown), Yunjie Yang, (unknown), Xiaoyan Li, (unknown), Ye Cao, Jundong Li, Jihong Liu, Li Su, Tao Liu, Yongwen Huang	1
3	Neglected Spleen Transcriptional Profile Reveals Inflammatory Disorder Conferred by Rabbit Hemorrhagic Disease Virus 2 Infection 2024 ·Viruses ·Jifeng Yu, Yan Li, (unknown), (unknown), Zhiqiang Guo, (unknown), (unknown), Ye Cao, (unknown), (unknown), Xingyu Li, (unknown), Jianqiang Ye, Long Zhou, Jian Huang, Junyan Yang, Yong Wei, Xianhui Zhang, (unknown), (unknown)	1
4	Enolase-based nanovaccine immersion immunization induces robust immunity and protection against Streptococcus infection in tilapia 2023 ·Aquaculture ·Jia Liu, Ye Cao, (unknown), Hui Du, Tianqiang Liu, Gao‐Xue Wang, Mingzhu Liu, Qing Wang, Pengfei Li, Erlong Wang	4
5	Exploring the Immunoprotective Potential of a Nanocarrier Immersion Vaccine Encoding Sip against Streptococcus Infection in Tilapia (Oreochromis niloticus) 2023 ·Vaccines ·Ye Cao, Jia Liu, Gaoyang Liu, (unknown), Tianqiang Liu, Gao‐Xue Wang, Qing Wang, (unknown), Erlong Wang	6
6	The landscape of investigator‐initiated oncology trials conducted in mainland China during the past decade (2010–2019) 2023 ·SHILAP Revista de lepidopterología ·Ye Cao, (unknown), (unknown), (unknown), Liying Chen, (unknown), (unknown), (unknown)	3
7	A subunit vaccine encoding glycoprotein holds potential to protect snakehead (Channa argus) from snakehead vesiculovirus infection 2023 ·Aquaculture ·(unknown), (unknown), Dexin Wang, Ye Cao, Jia Liu, Tianqiang Liu, Tao Liu, Gao‐Xue Wang, Erlong Wang	4
8	Diagnostic Yield of Exome Sequencing in Fetuses with Sonographic Features of Skeletal Dysplasias but Normal Karyotype or Chromosomal Microarray Analysis: A Systematic Review 2023 ·(unknown), (unknown), Rima Irwinda, Kwok Leung, Yuen Ha Ting, Ye Cao, Kwong Wai Choy	1
9	A nanocarrier immersion vaccine encoding surface immunogenic protein confers cross-immunoprotection against Streptococcus agalactiae and Streptococcus iniae infection in tilapia 2023 ·Fish & Shellfish Immunology ·Ye Cao, Jia Liu, Gaoyang Liu, Hui Du, Tianqiang Liu, Tao Liu, Pengfei Li, Qing Yu, Gao‐Xue Wang, Erlong Wang	5
10	BNC-rSS, a bivalent subunit nanovaccine affords the cross-protection against Streptococcus agalactiae and Streptococcus iniae infection in tilapia 2023 ·International Journal of Biological Macromolecules ·Jia Liu, Gaoyang Liu, Ye Cao, (unknown), Tianqiang Liu, Mingzhu Liu, Pengfei Li, Yang He, Gao‐Xue Wang, (unknown), Erlong Wang	6
11	Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review 2019 ·The Lancet Oncology ·Ning Li, Huiyao Huang, Dawei Wu, Zhimin Yang, Jun Wang, Jiansheng Wang, Shuhang Wang, Hong Fang, (unknown), Ying Bai, Yan Zhao, Ye Cao, Min Jiang, Yanfei Liu, Kunyan Li, Binghe Xu, Yan Sun, Jie He	63
12	Can increasing the prevalence of vegetable-based diets lower the risk of osteoporosis in postmenopausal subjects? A systematic review with meta-analysis of the literature 2018 ·Complementary Therapies in Medicine ·Lingfeng Zeng, Weiyi Yang, Guihong Liang, Minghui Luo, Ye Cao, Hongyun Chen, (unknown), Hetao Huang, Yanhong Han, Di Zhao, (unknown), (unknown), Aihua Ou, (unknown), Qi Wang, Jun Liu	8
13	Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine 2016 ·Cancer Research ·Yanxia Shi, (unknown), Ye Cao, Jianan Wang, Max M. He, Li Li, Jinfeng Zhang	18
14	Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer 2016 ·PLoS ONE ·Cong Xue, Roujun Peng, Ye Cao, Shusen Wang, Yanxia Shi, Xin An, Fei Xu, Zhongyu Yuan	2
15	Is adjunctive treatment with medication of liver-soothing-oriented method beneficial for depression after cerebrovascular accident? 2016 ·Medicine ·Lingfeng Zeng, (unknown), (unknown), Xiaoyan Chen, (unknown), Ziping Li, Qi Wang, Ye Cao, (unknown), (unknown), (unknown), Wang Ning-sheng	3
16	The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study 2015 ·Chinese Journal of Cancer ·Hang Yang, (unknown), Ye Cao, Ming Song, Xin An, Yi Xia, Jing Wei, Wen-Qi Jiang, Yan-Xia Shi	7
17	Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer 2012 ·Journal of Cancer Research and Clinical Oncology ·Yan-Xia Shi, Qing Xia, Roujun Peng, Zhong-Yu Yuan, Shu-Sen Wang, Xin An, Ye Cao, (unknown), Ying Jin, Xiu-Yu Cai, (unknown), Xiaoyu Teng, Dong-Geng Liu, Wen-Qi Jiang	33
18	Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer 2011 ·Medical Oncology ·Yanxia Shi, Yuting Tan, Zhongyu Yuan, Shusen Wang, Roujun Peng, Xin An, Ye Cao, Ying Jin, Xiuyu Cai, Yue-Li Sun, Xiaoyu Teng, Donggeng Liu	5
19	Zoledronic acid combined with chemotherapy bring survival benefits to patients with bone metastases from nasopharyngeal carcinoma 2011 ·Journal of Cancer Research and Clinical Oncology ·Ying Jin, Xin An, Yu Cai, Ye Cao, (unknown), Qing Xia, Yu Ting Tan, (unknown), Yan Shi	13
20	A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors 2007 ·Cancer Biology & Therapy ·(unknown), Huiqiang Huang, Su Li, Hongli Li, Yuhong Li, Ye Cao, Dongsheng Zhang, Yunfei Xia, (unknown), Wenlin Huang, Wenqi Jiang	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact